Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
9.34
+0.57 (6.50%)
At close: Sep 26, 2025, 4:00 PM EDT
9.44
+0.10 (1.07%)
After-hours: Sep 26, 2025, 7:45 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $848.18 million as of September 26, 2025. Its market cap has increased by 311.14% in one year.
Market Cap
848.18M
Enterprise Value
681.94M
1-Year Change
311.14%
Ranking
Category
Stock Price
$9.34
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $848.18M, an increase of 407.89%. That is a compound annual growth rate of 39.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 848.20M | 198.77% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |